tiprankstipranks
Trending News
More News >
Burcon Nutrascience (TSE:BU)
TSX:BU

Burcon Nutrascience (BU) Price & Analysis

Compare
76 Followers

BU Stock Chart & Stats

C$1.73
C$0.00(0.00%)
At close: 4:00 PM EST
C$1.73
C$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth MomentumSharp TTM revenue growth (+84.31%) demonstrates rising adoption of Burcon’s protein technologies and validates product-market fit. Sustained top-line momentum enhances bargaining power with partners, improves prospects for recurring licensing/royalty streams and supports scale-up efforts over the medium term.
IP-led, Asset-light ModelBurcon’s focus on licensing, royalties and partner commercialization is an IP-driven, asset-light model. This reduces capital intensity, enables scalable revenue via third-party manufacturing, and can generate high-margin, recurring income if licensing deals and partner rollouts progress as intended.
Feedstock And Product VersatilityTechnology applicable to multiple plant sources (pea, canola/rapeseed, soy, hemp) broadens addressable markets and reduces reliance on a single commodity. That versatility makes the IP appealing to a wider set of food ingredient partners and supports longer-term commercial opportunities across segments.
Bears Say
Balance Sheet DeteriorationNegative equity and elevated debt indicate a materially weakened balance sheet. Reduced financial flexibility increases refinancing and covenant risk, constrains the company’s ability to self-fund commercialization, and raises the likelihood of dilutive or expensive external financing over the coming months.
Weak Cash GenerationOperating cash flow and free cash flow have been negative in the TTM and in prior annual periods, reflecting persistent cash burn. Continued negative cash generation makes the business reliant on external funding, which can delay commercialization, slow partner rollouts, and pressure strategic options.
Sustained UnprofitabilityNegative gross profit and continued operating losses show Burcon has not reached a sustainable cost structure. Persistent unprofitability increases execution risk for converting R&D and pilot sales into durable, profitable licensing or ingredient revenues and may prolong dependence on outside capital.

Burcon Nutrascience News

BU FAQ

What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was C$1.51 and its highest was C$5.00 in the past 12 months.
    What is Burcon Nutrascience’s market cap?
    Burcon Nutrascience’s market cap is C$27.92M.
      When is Burcon Nutrascience’s upcoming earnings report date?
      Burcon Nutrascience’s upcoming earnings report date is Jul 01, 2026 which is in 110 days.
        How were Burcon Nutrascience’s earnings last quarter?
        Burcon Nutrascience released its earnings results on Feb 11, 2026. The company reported -C$0.28 earnings per share for the quarter, missing the consensus estimate of C$0 by -C$0.28.
          Is Burcon Nutrascience overvalued?
          According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Burcon Nutrascience pay dividends?
            Burcon Nutrascience does not currently pay dividends.
            What is Burcon Nutrascience’s EPS estimate?
            Burcon Nutrascience’s EPS estimate is -0.1.
              How many shares outstanding does Burcon Nutrascience have?
              Burcon Nutrascience has 12,692,276 shares outstanding.
                What happened to Burcon Nutrascience’s price movement after its last earnings report?
                Burcon Nutrascience reported an EPS of -C$0.28 in its last earnings report, missing expectations of C$0. Following the earnings report the stock price went up 1.596%.
                  Which hedge fund is a major shareholder of Burcon Nutrascience?
                  Currently, no hedge funds are holding shares in TSE:BU
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Burcon Nutrascience

                    Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include Peazazz, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; and Peazac and Peazac 850, a pea protein for plant-based meat alternative products, ready-to-mix powders, ready-to-mix beverages, dairy alternatives, and nutrition bars, as well as other applications requiring the most neutral flavor and moderate viscosity. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS and Nutratein-TZ, a blend of Peazac pea protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and other foods and nutritional products. Further, it provides MeritPro, a nutritional protein blend, including allergen-free, gluten-free, non-dairy, non-GMO, and vegan. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

                    Burcon Nutrascience (BU) Earnings & Revenues

                    BU Earnings Call

                    Q3 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The earnings call highlighted significant progress in production capabilities, customer engagement, and strategic agreements, with some concerns about onetime start-up costs. The overall tone was optimistic, focusing on execution and future growth potential.View all TSE:BU earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    DAVIDsTEA
                    Else Nutrition Holdings
                    Nepra Foods
                    Cult Food Science Corp.
                    Pangea Natural Food, Inc.
                    Popular Stocks